Sell. The evidence for MC-1 efficacy isn't remotely strong enough to warrant anything more than a trivial investment.
Plus MCU is headed for a disaster trying to sell tirofiban; getting uptake for this agent will require real expertise and substantial marketing spend. And as far as I can tell MCU has neither the expertise nor enough cash to do the job properly.
In short, let other investors suffer through this. If MC-1 is effective, there will be plenty of time to buy.
Market Data 
Markets 
AI
